Trials / Completed
CompletedNCT02507102
A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Nativis, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This feasibility study will assess the effects of the Nativis Voyager therapy in patients with recurrent GBM who have either failed standard of care or are intolerant to therapy. The study will enroll and treat up to eleven subjects over six months. Safety and clinical utility will be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Voyager | Non-invasive RFE therapy |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2017-12-01
- Completion
- 2018-03-26
- First posted
- 2015-07-23
- Last updated
- 2018-03-30
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT02507102. Inclusion in this directory is not an endorsement.